Westchester Medical Center’s David Kronn, MD, Presents at 14th Annual International Congress of Inborn Errors of Metabolism 2021 Conference
Dr. David Kronn, MD was a featured panelist for “Pursuing More Effective Diagnosis and Treatment of Pompe Disease: Applying New Advances into Practice” during the Annual International Congress of Inborn Errors of Metabolism 2021 Conference, which took place on November 22nd.
As noted in the symposium synopsis: "Pompe disease is a rare, inherited lysosomal storage disorder caused by aberrations in the glucosidase alpha (GAA) gene that lead to deficient GAA activity and a toxic buildup of glycogen in muscle and other tissues. It is classified as infantile-onset PD (IOPD) or late-onset PD (LOPD). Without ERT, IOPD is fatal by age 2 and LOPD is associated with varying degrees of morbidity and mortality. Early diagnosis is critical to ensure timely initiation of ERT and to improve long-term prognosis."
